You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
Can the length of our telomeres, the protective caps at the ends of chromosomes that wear down as we get old, predict how well our bodies will age and our vulnerability to chronic diseases? Two new companies, both with heavyweight academic backing, are betting on it and have started or are planning to start performing telomere tests for the general public this year. But other leading telomere scientists say such tests are premature, if not virtually useless. On opposite sides of the issue are former collaborators Elizabeth Blackburn and Carol Greider, who, along with Jack Szostak of Harvard Medical School, shared the 2009 Nobel Prize in physiology or medicine for their telomere discoveries.
